The effect of temperature and some mediator antagonists on anaphylactic shock in mice.
D000614:Aminocaproates / Q000627:therapeutic use*; D000632:Aminopyrine / Q000627:therapeutic use; D000707:Anaphylaxis / Q000276:immunology / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001886:Bordetella pertussis / Q000276:immunology; D004357:Drug Synergism; D005334:Fever; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D007035:Hypothermia; D008784:Methysergide / Q000627:therapeutic use; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use*; D013696:Temperature
D000614:Aminocaproates; D006634:Histamine H1 Antagonists; D000632:Aminopyrine; D007611:Aprotinin; D010653:Phenylbutazone; D001205:Ascorbic Acid; D008784:Methysergide